1-4 of 4
Hans Jansen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Atorvastatin Decreases Apolipoprotein C-III in Apolipoprotein B-Containing Lipoprotein and HDL in Type 2 Diabetes : A potential mechanism to lower plasma triglycerides

Geesje M. Dallinga-Thie, PHD, Ingrid I.L. Berk-Planken, MD, PHD, Aart H. Bootsma, MD, PHD, Hans Jansen, PHD, on behalf of the Diabetes Atorvastatin Lipid Intervention (DALI) Study Group
Journal: Diabetes Care
Diabetes Care 2004;27(6):1358–1364
https://doi.org/10.2337/diacare.27.6.1358
Published: 01 June 2004
View article titled, Atorvastatin Decreases Apolipoprotein C-III in Apolipoprotein B-Containing Lipoprotein and HDL in Type 2 Diabetes : <subtitle>A potential mechanism to lower plasma triglycerides </subtitle>
Open the PDF for Atorvastatin Decreases Apolipoprotein C-III in Apolipoprotein B-Containing Lipoprotein and HDL in Type 2 Diabetes : <subtitle>A potential mechanism to lower plasma triglycerides </subtitle> in another window
Journal Articles

The Relationship of Lipoprotein Lipase Activity and LDL size Is Dependent on Glucose Metabolism in an Elderly Population : The Hoorn Study

Griët Bos, MSC, Peter G. Scheffer, PHD, Delfina Vieira, PHD, Jacqueline M. Dekker, PHD, Giel Nijpels, PHD, Michaela Diamant, PHD, Tom Teerlink, PHD, Coen D.A. Stehouwer, PHD, Lex M. Bouter, PHD, Robert J. Heine, PHD, Hans Jansen, PHD
Journal: Diabetes Care
Diabetes Care 2004;27(3):796–798
https://doi.org/10.2337/diacare.27.3.796
Published: 01 March 2004
View article titled, The Relationship of Lipoprotein Lipase Activity and LDL size Is Dependent on Glucose Metabolism in an Elderly Population : <subtitle>The Hoorn Study</subtitle>
Open the PDF for The Relationship of Lipoprotein Lipase Activity and LDL size Is Dependent on Glucose Metabolism in an Elderly Population : <subtitle>The Hoorn Study</subtitle> in another window
Journal Articles

Atorvastatin Dose-Dependently Decreases Hepatic Lipase Activity in Type 2 Diabetes: Effect of sex and the LIPC promoter variant

Ingrid I.L. Berk-Planken, MD, Nicoline Hoogerbrugge, MD, PHD, Ronald P. Stolk, MD, PHD, Aart H. Bootsma, MD, PHD, Hans Jansen, MRBC, PHD, on behalf of the DALI study group
Journal: Diabetes Care
Diabetes Care 2003;26(2):427–432
https://doi.org/10.2337/diacare.26.2.427
Published: 01 February 2003
View article titled, Atorvastatin Dose-Dependently Decreases Hepatic Lipase Activity in Type 2 Diabetes: <subtitle>Effect of sex and the <em>LIPC</em> promoter variant</subtitle>
Open the PDF for Atorvastatin Dose-Dependently Decreases Hepatic Lipase Activity in Type 2 Diabetes: <subtitle>Effect of sex and the <em>LIPC</em> promoter variant</subtitle> in another window
Journal Articles

Atorvastatin, Diabetic Dyslipidemia, and Cognitive Functioning

Ingrid Berk-Planken, MD, Inge de Konig, MCRP, Ronald Stolk, MD, PHD, Hans Jansen, MRBC, PHD, Nicoline Hoogerbrugge, MD, PHD
Journal: Diabetes Care
Diabetes Care 2002;25(7):1250–1251
https://doi.org/10.2337/diacare.25.7.1250
Published: 01 July 2002
View article titled, Atorvastatin, Diabetic Dyslipidemia, and Cognitive Functioning
Open the PDF for Atorvastatin, Diabetic Dyslipidemia, and Cognitive Functioning in another window